Literature DB >> 7899484

Serial casting of the lower extremity to correct contractures during the acute phase of burn care.

J Johnson1, R Silverberg.   

Abstract

Severe contractures that develop early following a burn may not improve with splinting and exercise treatment. An alternative treatment is serial casting, which has been used to promote increased range of motion, to facilitate patient compliance with positioning, and to prevent the patient from scratching the burned area. This case report describes the use of serial casting for resolution of ankle plantar-flexion contractures that occurred in the acute phase of burn injury. The child described in this case report sustained a 49% total body surface area scald burn and developed contractures within 1 week after injury. The contractures, which were not corrected with thermoplastic splints, improved with casting from 45 degrees of plantar flexion to neutral dorsiflexion over 2 months with biweekly cast changes. The patient had multiple skin grafts and progressed in functional activities. Serial casting is a conservative and effective modality in correcting contractures resulting from burns. Further documentation of the efficacy of this treatment approach is necessary to support its use in burn care throughout various stages of healing.

Entities:  

Mesh:

Year:  1995        PMID: 7899484     DOI: 10.1093/ptj/75.4.262

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  2 in total

Review 1.  Rehabilitation in the Acute Versus Outpatient Setting.

Authors:  Gabriel Hundeshagen; Oscar E Suman; Ludwik K Branski
Journal:  Clin Plast Surg       Date:  2017-07-28       Impact factor: 2.017

2.  Pediatric Contractures in Burn Injury: A Burn Model System National Database Study.

Authors:  Jeremy Goverman; Katie Mathews; Richard Goldstein; Radha Holavanahalli; Karen Kowalske; Peter Esselman; Nicole Gibran; Oscar Suman; David Herndon; Colleen M Ryan; Jeffrey C Schneider
Journal:  J Burn Care Res       Date:  2017 Jan/Feb       Impact factor: 1.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.